期刊文献+

多重耐药阴沟肠杆菌临床分离株ESBLs基因型别和分子流行病学分析 预览 被引量:9

Multidrug-resistant Clinical Enterobacter cloacae Isolates: Analysis of Their ESBLs Gene Types and Molecular Epidemiology
在线阅读 下载PDF
分享 导出
摘要 目的 了解引起医院感染的阴沟肠杆菌临床菌株ESBLs的分布及流行情况,为控制ESBLs流行提供依据.方法 连续收集了27株不重复的对头孢他啶或头孢噻肟耐药的阴沟肠杆菌临床菌株,采用系列ESBLs特异性引物进行PCR,并对PCR产物测序;同时采用ERIC2引物进行rep-PCR.结果 对头孢他啶或头孢噻肟耐药的阴沟肠杆菌临床菌株中最为流行的ESBLs是CTX-M-3样(13株阳性,占48%);在我国首次发现肠杆菌科细菌中有VEB-1样β-内酰胺酶流行;产ESBLs阴沟肠杆菌大多具有克隆相关性,它们在流行过程中又分别获得了不同的ESBLs耐药基因.结论 上海华山医院引起医院感染的阴沟肠杆菌ESBLs产生率高,是阴沟肠杆菌对β-内酰胺类药物耐药的重要原因. OBJECTIVE To understand the distribution and epidemiology of ESBLs in ceftazidime or cefotaxime-resistant clinical Enterobacter cloacae isolates. METHODS Twenty seven ceftazidime or cefotaxime-resistant nonrepetitive E. cloacae were collected from 27 patients hospitalized at the Huashan Hospital, Shanghai. PCR and sequencing were performed to understand the distribution of ESBLs in E. cloacae; rep-PCR was performed to understand the epidemiology of ESBLs in E. cloacae. RESULTS CTX-M-3 like ESBLs were the most prevalent in our study (48%); this was the first report of VEB-1-like ESBLs in the member of Enterobacteriaceae in China, and the first report of the ESBLs VEB-1-like and CTX-M-3-like in an isolate simultaneously; the majority of ESBLs producers exhibited the same rep-PCR pattern, but harbored different ESBLs gene. CONCLUSIONS In our study, ESBLs have become prevalent in clinical E. cloacae isolates, and become an important factor of E. cloacae isolates resistant to extended-spectrum beta-lactams.
作者 刘红 蒋晓飞 阮斐怡 李敏 艾芙琪 马逸珉 洪秀华 吕元 LIU Hong, JIANG Xiao-fei, RUAN Fei-yi, LI Min, AI Fu-qi, MA Yi-min, HONG Xiu-hua, Lü Yuan(Huashan Hospital, Fudan University, Shanghai 200040, China)
出处 《中华医院感染学杂志》 CAS 北大核心 2006年第5期 489-492,共4页 Chinese Journal of Nosocomiology
基金 上海市卫生局局级资助科研课题(69).
关键词 阴沟肠杆菌 Β-内酰胺酶类 PCR Enterobacter cloacaet beta-lactamases PCR
  • 相关文献

参考文献7

二级参考文献17

  • 1Jones RN. Importment and emerging β-lactamase-mediated resistanee in hospital-based pathogens: the AmpC enzymes[J].Diagn Mierobiol Infect Dis, 1998, 31.-461-466. 被引量:1
  • 2Langaee TY, Gagnon L, Huletsky A. Inactivation of the AmpD gene in Pseudomonas aeruginosa leads to moderatebasal-level and hyperinducible AmpCβ-lactamase expression[J]. Antimicrob Agents Chemother, 2000, 44:583-589. 被引量:1
  • 3Korfmann G, Sanders CC, Moland ES. Altered phenotypes associated with AmpD mutation in E. cloacae[J]. Antimicrob Agents Chemother, 1991, 35:358-364. 被引量:1
  • 4Chan WC, Li RC, Ling JM, et al. Markedly different rates and resistance profiles exhibited by seven commonly used and newer β-lactams on the selection of resistant variants of Enterobacter cloacae[J]. J Antimicrob Chemother, 1999, 44:55-60. 被引量:1
  • 5Lauretti L,Riccio ML,Mazzariol A,et al.Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate[].Antimicrobial Agents and Chemotherapy.1999 被引量:1
  • 6Rasmussen BA,Bush K.Carbapenem-hydrolyzingβ-lactamases[].Antimicrobial Agents and Chemotherapy.1997 被引量:1
  • 7Nordmann P,Ronco E,Naas T,et al.Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa[].Antimicrobial Agents and Chemotherapy.1993 被引量:1
  • 8Coudron PE,Moland ES.Occurrence and detection of AmpC beta-lactamases among Escherichia coli , Klebsiella pneumoniae , and Proteus mirabilis isolates at a Veterans Medical Center[].Journal of Clinical Microbiology.2000 被引量:1
  • 9Naas T,Philippon L,Poirel L,et al.An SHV-derived extended-spectrum-βlactamase in Pseudomonas aeruginosa[].Antimicrobial Agents and Chemotherapy.1999 被引量:1
  • 10Poirel L,Naas T,Nicolas D,et al.Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integronborne gene from a Pseudomonas aeruginosa clinical isolate in France[].Antimicrobial Agents and Chemotherapy.2000 被引量:1

共引文献142

同被引文献65

引证文献9

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈